Global Angiopoietin 2 Market Insights and Forecast to 2026
Table of Contents1 Study Coverage
1.1 Angiopoietin 2 Product Introduction
1.2 Market Segments
1.3 Key Angiopoietin 2 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Angiopoietin 2 Market Size Growth Rate by Type
1.4.2 Atu-111
1.4.3 BI-836880
1.4.4 LY-3127804
1.4.5 MEDI-3617
1.4.6 Others
1.5 Market by Application
1.5.1 Global Angiopoietin 2 Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Angiopoietin 2 Market Size, Estimates and Forecasts
2.1.1 Global Angiopoietin 2 Revenue 2015-2026
2.1.2 Global Angiopoietin 2 Sales 2015-2026
2.2 Global Angiopoietin 2, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Angiopoietin 2 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Angiopoietin 2 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Angiopoietin 2 Competitor Landscape by Players
3.1 Angiopoietin 2 Sales by Manufacturers
3.1.1 Angiopoietin 2 Sales by Manufacturers (2015-2020)
3.1.2 Angiopoietin 2 Sales Market Share by Manufacturers (2015-2020)
3.2 Angiopoietin 2 Revenue by Manufacturers
3.2.1 Angiopoietin 2 Revenue by Manufacturers (2015-2020)
3.2.2 Angiopoietin 2 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Angiopoietin 2 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Angiopoietin 2 Revenue in 2019
3.2.5 Global Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Angiopoietin 2 Price by Manufacturers
3.4 Angiopoietin 2 Manufacturing Base Distribution, Product Types
3.4.1 Angiopoietin 2 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Angiopoietin 2 Product Type
3.4.3 Date of International Manufacturers Enter into Angiopoietin 2 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Angiopoietin 2 Market Size by Type (2015-2020)
4.1.1 Global Angiopoietin 2 Sales by Type (2015-2020)
4.1.2 Global Angiopoietin 2 Revenue by Type (2015-2020)
4.1.3 Angiopoietin 2 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Angiopoietin 2 Market Size Forecast by Type (2021-2026)
4.2.1 Global Angiopoietin 2 Sales Forecast by Type (2021-2026)
4.2.2 Global Angiopoietin 2 Revenue Forecast by Type (2021-2026)
4.2.3 Angiopoietin 2 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Angiopoietin 2 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Angiopoietin 2 Market Size by Application (2015-2020)
5.1.1 Global Angiopoietin 2 Sales by Application (2015-2020)
5.1.2 Global Angiopoietin 2 Revenue by Application (2015-2020)
5.1.3 Angiopoietin 2 Price by Application (2015-2020)
5.2 Angiopoietin 2 Market Size Forecast by Application (2021-2026)
5.2.1 Global Angiopoietin 2 Sales Forecast by Application (2021-2026)
5.2.2 Global Angiopoietin 2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Angiopoietin 2 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Angiopoietin 2 by Country
6.1.1 North America Angiopoietin 2 Sales by Country
6.1.2 North America Angiopoietin 2 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Angiopoietin 2 Market Facts & Figures by Type
6.3 North America Angiopoietin 2 Market Facts & Figures by Application
7 Europe
7.1 Europe Angiopoietin 2 by Country
7.1.1 Europe Angiopoietin 2 Sales by Country
7.1.2 Europe Angiopoietin 2 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Angiopoietin 2 Market Facts & Figures by Type
7.3 Europe Angiopoietin 2 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Angiopoietin 2 by Region
8.1.1 Asia Pacific Angiopoietin 2 Sales by Region
8.1.2 Asia Pacific Angiopoietin 2 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Angiopoietin 2 Market Facts & Figures by Type
8.3 Asia Pacific Angiopoietin 2 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Angiopoietin 2 by Country
9.1.1 Latin America Angiopoietin 2 Sales by Country
9.1.2 Latin America Angiopoietin 2 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Angiopoietin 2 Market Facts & Figures by Type
9.3 Central & South America Angiopoietin 2 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Angiopoietin 2 by Country
10.1.1 Middle East and Africa Angiopoietin 2 Sales by Country
10.1.2 Middle East and Africa Angiopoietin 2 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Angiopoietin 2 Market Facts & Figures by Type
10.3 Middle East and Africa Angiopoietin 2 Market Facts & Figures by Application
11 Company Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Corporation Information
11.1.2 Amgen Inc. Description and Business Overview
11.1.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc. Angiopoietin 2 Products Offered
11.1.5 Amgen Inc. Related Developments
11.2 AnGes MG, Inc.
11.2.1 AnGes MG, Inc. Corporation Information
11.2.2 AnGes MG, Inc. Description and Business Overview
11.2.3 AnGes MG, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AnGes MG, Inc. Angiopoietin 2 Products Offered
11.2.5 AnGes MG, Inc. Related Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Corporation Information
11.3.2 Boehringer Ingelheim GmbH Description and Business Overview
11.3.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Products Offered
11.3.5 Boehringer Ingelheim GmbH Related Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Description and Business Overview
11.4.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly and Company Angiopoietin 2 Products Offered
11.4.5 Eli Lilly and Company Related Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Products Offered
11.5.5 F. Hoffmann-La Roche Ltd. Related Developments
11.6 MedImmune, LLC
11.6.1 MedImmune, LLC Corporation Information
11.6.2 MedImmune, LLC Description and Business Overview
11.6.3 MedImmune, LLC Sales, Revenue and Gross Margin (2015-2020)
11.6.4 MedImmune, LLC Angiopoietin 2 Products Offered
11.6.5 MedImmune, LLC Related Developments
11.7 Regeneron Pharmaceuticals, Inc.
11.7.1 Regeneron Pharmaceuticals, Inc. Corporation Information
11.7.2 Regeneron Pharmaceuticals, Inc. Description and Business Overview
11.7.3 Regeneron Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Products Offered
11.7.5 Regeneron Pharmaceuticals, Inc. Related Developments
11.8 RXi Pharmaceuticals Corporation
11.8.1 RXi Pharmaceuticals Corporation Corporation Information
11.8.2 RXi Pharmaceuticals Corporation Description and Business Overview
11.8.3 RXi Pharmaceuticals Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Products Offered
11.8.5 RXi Pharmaceuticals Corporation Related Developments
11.9 Silence Therapeutics Plc
11.9.1 Silence Therapeutics Plc Corporation Information
11.9.2 Silence Therapeutics Plc Description and Business Overview
11.9.3 Silence Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Silence Therapeutics Plc Angiopoietin 2 Products Offered
11.9.5 Silence Therapeutics Plc Related Developments
11.10 Synergys Biotherapeutics, Inc.
11.10.1 Synergys Biotherapeutics, Inc. Corporation Information
11.10.2 Synergys Biotherapeutics, Inc. Description and Business Overview
11.10.3 Synergys Biotherapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Products Offered
11.10.5 Synergys Biotherapeutics, Inc. Related Developments
11.1 Amgen Inc.
11.1.1 Amgen Inc. Corporation Information
11.1.2 Amgen Inc. Description and Business Overview
11.1.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc. Angiopoietin 2 Products Offered
11.1.5 Amgen Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Angiopoietin 2 Market Estimates and Projections by Region
12.1.1 Global Angiopoietin 2 Sales Forecast by Regions 2021-2026
12.1.2 Global Angiopoietin 2 Revenue Forecast by Regions 2021-2026
12.2 North America Angiopoietin 2 Market Size Forecast (2021-2026)
12.2.1 North America: Angiopoietin 2 Sales Forecast (2021-2026)
12.2.2 North America: Angiopoietin 2 Revenue Forecast (2021-2026)
12.2.3 North America: Angiopoietin 2 Market Size Forecast by Country (2021-2026)
12.3 Europe Angiopoietin 2 Market Size Forecast (2021-2026)
12.3.1 Europe: Angiopoietin 2 Sales Forecast (2021-2026)
12.3.2 Europe: Angiopoietin 2 Revenue Forecast (2021-2026)
12.3.3 Europe: Angiopoietin 2 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Angiopoietin 2 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Angiopoietin 2 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Angiopoietin 2 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Angiopoietin 2 Market Size Forecast by Region (2021-2026)
12.5 Latin America Angiopoietin 2 Market Size Forecast (2021-2026)
12.5.1 Latin America: Angiopoietin 2 Sales Forecast (2021-2026)
12.5.2 Latin America: Angiopoietin 2 Revenue Forecast (2021-2026)
12.5.3 Latin America: Angiopoietin 2 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Angiopoietin 2 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Angiopoietin 2 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Angiopoietin 2 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Angiopoietin 2 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Angiopoietin 2 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Angiopoietin 2 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Angiopoietin 2 Market Segments
Table 2. Ranking of Global Top Angiopoietin 2 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Angiopoietin 2 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Atu-111
Table 5. Major Manufacturers of BI-836880
Table 6. Major Manufacturers of LY-3127804
Table 7. Major Manufacturers of MEDI-3617
Table 8. Major Manufacturers of Others
Table 9. Global Angiopoietin 2 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Angiopoietin 2 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Angiopoietin 2 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Angiopoietin 2 Sales Market Share by Regions (2015-2020)
Table 13. Global Angiopoietin 2 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Angiopoietin 2 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Angiopoietin 2 Sales Share by Manufacturers (2015-2020)
Table 16. Global Angiopoietin 2 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Angiopoietin 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiopoietin 2 as of 2019)
Table 18. Angiopoietin 2 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Angiopoietin 2 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Angiopoietin 2 Price (2015-2020) (USD/Pcs)
Table 21. Angiopoietin 2 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Angiopoietin 2 Product Type
Table 23. Date of International Manufacturers Enter into Angiopoietin 2 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Angiopoietin 2 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Angiopoietin 2 Sales Share by Type (2015-2020)
Table 27. Global Angiopoietin 2 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Angiopoietin 2 Revenue Share by Type (2015-2020)
Table 29. Angiopoietin 2 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Angiopoietin 2 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Angiopoietin 2 Sales Share by Application (2015-2020)
Table 32. North America Angiopoietin 2 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Angiopoietin 2 Sales Market Share by Country (2015-2020)
Table 34. North America Angiopoietin 2 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Angiopoietin 2 Revenue Market Share by Country (2015-2020)
Table 36. North America Angiopoietin 2 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 38. North America Angiopoietin 2 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 40. Europe Angiopoietin 2 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Angiopoietin 2 Sales Market Share by Country (2015-2020)
Table 42. Europe Angiopoietin 2 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Angiopoietin 2 Revenue Market Share by Country (2015-2020)
Table 44. Europe Angiopoietin 2 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 46. Europe Angiopoietin 2 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Angiopoietin 2 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Angiopoietin 2 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Angiopoietin 2 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Angiopoietin 2 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Angiopoietin 2 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Angiopoietin 2 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 56. Latin America Angiopoietin 2 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Angiopoietin 2 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Angiopoietin 2 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Angiopoietin 2 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Angiopoietin 2 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 62. Latin America Angiopoietin 2 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Angiopoietin 2 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Angiopoietin 2 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Angiopoietin 2 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Angiopoietin 2 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Angiopoietin 2 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Angiopoietin 2 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 72. Amgen Inc. Corporation Information
Table 73. Amgen Inc. Description and Major Businesses
Table 74. Amgen Inc. Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Amgen Inc. Product
Table 76. Amgen Inc. Recent Development
Table 77. AnGes MG, Inc. Corporation Information
Table 78. AnGes MG, Inc. Description and Major Businesses
Table 79. AnGes MG, Inc. Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AnGes MG, Inc. Product
Table 81. AnGes MG, Inc. Recent Development
Table 82. Boehringer Ingelheim GmbH Corporation Information
Table 83. Boehringer Ingelheim GmbH Description and Major Businesses
Table 84. Boehringer Ingelheim GmbH Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Boehringer Ingelheim GmbH Product
Table 86. Boehringer Ingelheim GmbH Recent Development
Table 87. Eli Lilly and Company Corporation Information
Table 88. Eli Lilly and Company Description and Major Businesses
Table 89. Eli Lilly and Company Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Eli Lilly and Company Product
Table 91. Eli Lilly and Company Recent Development
Table 92. F. Hoffmann-La Roche Ltd. Corporation Information
Table 93. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 94. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. F. Hoffmann-La Roche Ltd. Product
Table 96. F. Hoffmann-La Roche Ltd. Recent Development
Table 97. MedImmune, LLC Corporation Information
Table 98. MedImmune, LLC Description and Major Businesses
Table 99. MedImmune, LLC Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. MedImmune, LLC Product
Table 101. MedImmune, LLC Recent Development
Table 102. Regeneron Pharmaceuticals, Inc. Corporation Information
Table 103. Regeneron Pharmaceuticals, Inc. Description and Major Businesses
Table 104. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Regeneron Pharmaceuticals, Inc. Product
Table 106. Regeneron Pharmaceuticals, Inc. Recent Development
Table 107. RXi Pharmaceuticals Corporation Corporation Information
Table 108. RXi Pharmaceuticals Corporation Description and Major Businesses
Table 109. RXi Pharmaceuticals Corporation Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. RXi Pharmaceuticals Corporation Product
Table 111. RXi Pharmaceuticals Corporation Recent Development
Table 112. Silence Therapeutics Plc Corporation Information
Table 113. Silence Therapeutics Plc Description and Major Businesses
Table 114. Silence Therapeutics Plc Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Silence Therapeutics Plc Product
Table 116. Silence Therapeutics Plc Recent Development
Table 117. Synergys Biotherapeutics, Inc. Corporation Information
Table 118. Synergys Biotherapeutics, Inc. Description and Major Businesses
Table 119. Synergys Biotherapeutics, Inc. Angiopoietin 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Synergys Biotherapeutics, Inc. Product
Table 121. Synergys Biotherapeutics, Inc. Recent Development
Table 122. Global Angiopoietin 2 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 123. Global Angiopoietin 2 Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Angiopoietin 2 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Angiopoietin 2 Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Angiopoietin 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. North America: Angiopoietin 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Angiopoietin 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Europe: Angiopoietin 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Angiopoietin 2 Sales Forecast by Region (2021-2026) (K Pcs)
Table 131. Asia Pacific: Angiopoietin 2 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Angiopoietin 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. Latin America: Angiopoietin 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Angiopoietin 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 135. Middle East and Africa: Angiopoietin 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Angiopoietin 2 Players
Table 140. Angiopoietin 2 Customers List
Table 141. Angiopoietin 2 Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of FiguresFigure 1. Angiopoietin 2 Product Picture
Figure 2. Global Angiopoietin 2 Sales Market Share by Type in 2020 & 2026
Figure 3. Atu-111 Product Picture
Figure 4. BI-836880 Product Picture
Figure 5. LY-3127804 Product Picture
Figure 6. MEDI-3617 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Angiopoietin 2 Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Angiopoietin 2 Report Years Considered
Figure 13. Global Angiopoietin 2 Market Size 2015-2026 (US$ Million)
Figure 14. Global Angiopoietin 2 Sales 2015-2026 (K Pcs)
Figure 15. Global Angiopoietin 2 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Angiopoietin 2 Sales Market Share by Region (2015-2020)
Figure 17. Global Angiopoietin 2 Sales Market Share by Region in 2019
Figure 18. Global Angiopoietin 2 Revenue Market Share by Region (2015-2020)
Figure 19. Global Angiopoietin 2 Revenue Market Share by Region in 2019
Figure 20. Global Angiopoietin 2 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Angiopoietin 2 Revenue in 2019
Figure 22. Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Angiopoietin 2 Sales Market Share by Type (2015-2020)
Figure 24. Global Angiopoietin 2 Sales Market Share by Type in 2019
Figure 25. Global Angiopoietin 2 Revenue Market Share by Type (2015-2020)
Figure 26. Global Angiopoietin 2 Revenue Market Share by Type in 2019
Figure 27. Global Angiopoietin 2 Market Share by Price Range (2015-2020)
Figure 28. Global Angiopoietin 2 Sales Market Share by Application (2015-2020)
Figure 29. Global Angiopoietin 2 Sales Market Share by Application in 2019
Figure 30. Global Angiopoietin 2 Revenue Market Share by Application (2015-2020)
Figure 31. Global Angiopoietin 2 Revenue Market Share by Application in 2019
Figure 32. North America Angiopoietin 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Angiopoietin 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Angiopoietin 2 Sales Market Share by Country in 2019
Figure 35. North America Angiopoietin 2 Revenue Market Share by Country in 2019
Figure 36. U.S. Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Angiopoietin 2 Market Share by Type in 2019
Figure 41. North America Angiopoietin 2 Market Share by Application in 2019
Figure 42. Europe Angiopoietin 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Angiopoietin 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Angiopoietin 2 Sales Market Share by Country in 2019
Figure 45. Europe Angiopoietin 2 Revenue Market Share by Country in 2019
Figure 46. Germany Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Angiopoietin 2 Market Share by Type in 2019
Figure 57. Europe Angiopoietin 2 Market Share by Application in 2019
Figure 58. Asia Pacific Angiopoietin 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Angiopoietin 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Angiopoietin 2 Sales Market Share by Region in 2019
Figure 61. Asia Pacific Angiopoietin 2 Revenue Market Share by Region in 2019
Figure 62. China Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Angiopoietin 2 Market Share by Type in 2019
Figure 85. Asia Pacific Angiopoietin 2 Market Share by Application in 2019
Figure 86. Latin America Angiopoietin 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Angiopoietin 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Angiopoietin 2 Sales Market Share by Country in 2019
Figure 89. Latin America Angiopoietin 2 Revenue Market Share by Country in 2019
Figure 90. Mexico Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Angiopoietin 2 Market Share by Type in 2019
Figure 97. Latin America Angiopoietin 2 Market Share by Application in 2019
Figure 98. Middle East and Africa Angiopoietin 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Angiopoietin 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Angiopoietin 2 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Angiopoietin 2 Revenue Market Share by Country in 2019
Figure 102. Turkey Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Angiopoietin 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Angiopoietin 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Angiopoietin 2 Market Share by Type in 2019
Figure 109. Middle East and Africa Angiopoietin 2 Market Share by Application in 2019
Figure 110. North America Angiopoietin 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Angiopoietin 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Angiopoietin 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Angiopoietin 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Angiopoietin 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Angiopoietin 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Angiopoietin 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Angiopoietin 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Angiopoietin 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Angiopoietin 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed